Peter Oppelt, MD

Medical Oncologist

Primary Academic Title

Associate Professor of Medicine, Division of Oncology, Section of Medical Oncology, WashU Medicine

Clinical Expertise

head and neck

Education

2008: MD, University of Missouri, Columbia

Training

2008 - 2011: Resident, internal medicine, University Hospitals Case Medical Center, Cleveland
2011 - 2012: Chief medical resident, internal medicine, University Hospitals Case Medical Center
2012 - 2015: Fellow, hematology and oncology, University Hospitals Case Medical Center

Board Certification

2011: American Board of Internal Medicine
2015: American Board of Internal Medicine - Medical Oncology
2015: American Board of Internal Medicine - Hematology

Selected Research Publications

Neoadjuvant BMS-813160, nivolumab, gemcitabine and nab-paclitaxel for patients with pancreatic cancer.

Grierson PM, Wolf C, Suresh R, [...] Oppelt P, [...] Lim KH
Clin Cancer Res 2025

Tazemetostat, a Selective EZH2 Inhibitor, in Combination with Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 1 Trial.

Oppelt PJ, Puram SV, Liu J, Ley JC , Adkins D
Cancers (Basel) 2025

Pembrolizumab Plus Carboplatin and Paclitaxel as First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-B10): A Single-Arm Phase IV Trial.

Dzienis M, Cundom J, Fuentes CS, [...] Oppelt P, [...] de Castro G
J Clin Oncol 2024

Ramucirumab in combination with pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma: a single-centre, phase 1/2 trial.

Adkins D, Ley JC, Liu J, Oppelt P
Lancet Oncol 2024

A Phase I, Multicenter, Open-Label, First-in-Human Study of DS-6157a in Patients with Advanced Gastrointestinal Stromal Tumor.

George S, Heinrich MC, Somaiah N, Oppelt P, [...] Naito Y
Clin Cancer Res 2023

Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti-PD-1 in head and neck cancer.

Oliveira G, Egloff AM, Afeyan AB, [...] Oppelt P, [...] Uppaluri R
Sci Immunol 2023

A Single-Arm Phase II Trial of Sitravatinib in Advanced Well-Differentiated/Dedifferentiated Liposarcoma.

Ingham M, Lee S, Van Tine BA, [...] Oppelt P, [...] Schwartz GK
Clin Cancer Res 2023

The Potential for Selective Cyclin-Dependent Kinase 4/6 Inhibition in the Therapy for Head and Neck Squamous Cell Carcinoma.

Adkins D, Ley J, Cohen J, Oppelt P
Cancer J 2022

Contact Information

Gary C. Werths Building at Siteman Cancer Center

4500 Forest Park Avenue
Saint Louis, MO 63108
West St. Louis County

Medical Office Building 2, 10 Barnes West Drive
Creve Coeur, MO 63141
St. Charles County

150 Entrance Way
St. Peters, MO 63376
Illinois

1418 Cross St.
Shiloh, IL 62269

Phone Numbers

Appointments: (314) 747-7222
Toll Free: (800) 600-3606

Request an appointment